AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3970797 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine combined with methohexitone
Number of subjects: 0
Study 3970797 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate combined with methohexitone
Number of subjects: 0
Study 3970797 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine combined with thiopentone
Number of subjects: 0
Study 3970797 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexitone
Number of subjects: 0
Study 3970797 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 0
Study 30601885 — intervention group
Group type: EXPERIMENTAL
Intervention: NCES and NDCS (subgroup 1B)
Number of subjects: 40
Study 30601885 — intervention group
Group type: COMPARATOR
Intervention: NCES (subgroup 1A)
Number of subjects: 40
Study 30601885 — intervention group
Group type: COMPARATOR
Intervention: NCES (subgroup 2A)
Number of subjects: 40
Study 30601885 — intervention group
Group type: EXPERIMENTAL
Intervention: NCES and NDCS (subgroup 2B)
Number of subjects: 40
Study 29582891 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of farmed salmon three times a week during 23 weeks
Number of subjects: 84
Study 29582891 — intervention group
Group type: COMPARATOR
Intervention: Control meal (meat) three times a week during 23 weeks
Number of subjects: 84
Study 30640988 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-hyperthermia foot bath with syndrome typing of Chinese medicine (CM), 30 min each time, once per day for 3 months
Number of subjects: 120
Study 30640988 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment of Western medicine (WM)
Number of subjects: 120
Study 30640988 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-hyperthermia foot bath with syndrome typing of Chinese medicine (CM)
Number of subjects: 120
Study 24473372 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (80 mg)
Number of subjects: 60
Study 24473372 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam
Number of subjects: 60
Study 24473372 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study 22532661 — intervention group
Group type: EXPERIMENTAL
Intervention: High concentration oxygen (8 L/min via medium concentration mask)
Number of subjects: 150
Study 22532661 — intervention group
Group type: COMPARATOR
Intervention: Titrated oxygen (to achieve oxygen saturations between 93 and 95%)
Number of subjects: 150
Study 20822038 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl pectin nasal spray (FPNS)
Number of subjects: 114
Study 20822038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 18773728 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal presentation of famous attractive faces
Number of subjects: 0
Study 18773728 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal presentation of unfamiliar attractive faces
Number of subjects: 0
Study 18773728 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal presentation of unfamiliar less attractive faces
Number of subjects: 0
Study 18773728 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraliminal presentation of faces
Number of subjects: 0
Study 15705007 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg b.i.d.)
Number of subjects: 35
Study 15705007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 14625517 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (10 g/day for 4 days)
Number of subjects: 21
Study 14625517 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (25 g/day for 4 days)
Number of subjects: 21
Study 14625517 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (35 g/day for 4 days)
Number of subjects: 21
Study 14625517 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 21
Study 10375051 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline binge eating status
Number of subjects: 444
Study 10375051 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in Binge Eating Scale (BES) scores
Number of subjects: 444
Study 10375051 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in Binge Eating Scale (BES) scores with depression scores included
Number of subjects: 444
Study 8836747 — intervention group
Group type: EXPERIMENTAL
Intervention: DNR patients in the special care unit
Number of subjects: 220
Study 8836747 — intervention group
Group type: COMPARATOR
Intervention: Non-DNR patients
Number of subjects: 220
Study 8836747 — intervention group
Group type: EXPERIMENTAL
Intervention: DNR patients
Number of subjects: 220
Study 1892004 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpirome 0.5 g b.i.d. (1 g group)
Number of subjects: 530
Study 1892004 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpirome 1.0 g b.i.d. (2 g group)
Number of subjects: 530
Study 1892004 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime 1.0 g b.i.d. (CAZ group)
Number of subjects: 530
Study 6436732 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate intake (rapidly or slowly absorbed sugars, given by mouth or IV injection)
Number of subjects: 0
Study 6436732 — intervention group
Group type: COMPARATOR
Intervention: Sodium valproate
Number of subjects: 0
Study 30371759 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Blood Pressure Monitoring (HBPM)
Number of subjects: 213
Study 30371759 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 213
Study 29846606 — intervention group
Group type: EXPERIMENTAL
Intervention: Sila-Mix (MIX)
Number of subjects: 2
Study 29846606 — intervention group
Group type: EXPERIMENTAL
Intervention: Sila-Max (MAX)
Number of subjects: 2
Study 29846606 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 2
Study 27006655 — intervention group
Group type: EXPERIMENTAL
Intervention: 2800 IU vitamin D3 daily for eight weeks
Number of subjects: 200
Study 27006655 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo for eight weeks
Number of subjects: 200
Study 24809432 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory ribcage compression (ERCC) before endotracheal suctioning
Number of subjects: 70
Study 24809432 — intervention group
Group type: COMPARATOR
Intervention: Control (no ERCC before endotracheal suctioning)
Number of subjects: 70
Study 22853731 — intervention group
Group type: EXPERIMENTAL
Intervention: Low number of symptoms (0-12 symptoms)
Number of subjects: 110
Study 22853731 — intervention group
Group type: EXPERIMENTAL
Intervention: High number of symptoms (13-32 symptoms)
Number of subjects: 110
Study 20528599 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting beta-agonists (LABAs)
Number of subjects: 0
Study 20528599 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-control methodology
Number of subjects: 0
Study 20528599 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0
Study 17609661 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HRQOL scores (EORTC QLQ‐C30 and BN 20)
Number of subjects: 490
Study 17609661 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical analysis
Number of subjects: 490
Study 17609661 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined analyses (bootstrap re‐sampling, C‐indexes, R(2)‐coefficients)
Number of subjects: 490
Study 18623040 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI
Number of subjects: 28
Study 18623040 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI (various strengths)
Number of subjects: 28
Study 18623040 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI (steady state)
Number of subjects: 28
Study 18623040 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI (repeated dose)
Number of subjects: 28
Study 14870994 — intervention group
Group type: EXPERIMENTAL
Intervention: Statewide home-visiting program to prevent child abuse
Number of subjects: 643
Study 11380135 — intervention group
Group type: EXPERIMENTAL
Intervention: Medoff sliding plate (MSP)
Number of subjects: 114
Study 11380135 — intervention group
Group type: COMPARATOR
Intervention: Compression hip screw (CHS)
Number of subjects: 114
Study 9423749 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate 50 mg/m2
Number of subjects: 20
Study 9423749 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate 60 mg/m2
Number of subjects: 20
Study 9423749 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate 50 mg/m2 and 60 mg/m2
Number of subjects: 20
Study 8255928 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2% escin gel
Number of subjects: 0
Study 8255928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3307307 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation 2,000 mg daily
Number of subjects: 28
Study 3307307 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 28
Study 31794102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral Er: YAG laser (SMOOTH mode)
Number of subjects: 20
Study 31794102 — intervention group
Group type: COMPARATOR
Intervention: Extraoral approach
Number of subjects: 20
Study 31152567 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using toluidine blue (10 mg/mL; 3 min) and a 635-nm laser (750 mW; 10 s/implant side; minimum of 60 mW/cm2)
Number of subjects: 131
Study 31152567 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 131
Study 27029960 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity isometric handgrip exercise (4×2 minutes sustained contractions at 30% of maximal volitional contraction interspersed with 1‐minute rest intervals)
Number of subjects: 15
Study 27029960 — intervention group
Group type: COMPARATOR
Intervention: Control (rest for 15 minutes)
Number of subjects: 15
Study 27029960 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity isometric handgrip exercise
Number of subjects: 15
Study 27029960 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study 25564396 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld echocardiography (HAND)
Number of subjects: 4773
Study 25564396 — intervention group
Group type: COMPARATOR
Intervention: Standard portable echocardiography (STAND)
Number of subjects: 4773
Study 23336469 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention (single nurse consultation and self-help manual)
Number of subjects: 212
Study 23336469 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study 22295386 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Needle Aspiration (PNA)
Number of subjects: 82
Study 22295386 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Catheter Drainage (PCD)
Number of subjects: 82
Study 19408467 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted implement training
Number of subjects: 48
Study 17343009 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM)
Number of subjects: 0
Study 17343009 — intervention group
Group type: EXPERIMENTAL
Intervention: Scientific evaluation of clinical efficacy
Number of subjects: 0
Study 17343009 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol design for TCM clinical therapeutic research
Number of subjects: 0
Study 14976601 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (DF)
Number of subjects: 332
Study 14976601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study 11996212 — intervention group
Group type: EXPERIMENTAL
Intervention: Metadate CD (20 mg capsule)
Number of subjects: 60
Study 11996212 — intervention group
Group type: COMPARATOR
Intervention: Concerta (18 mg tablet)
Number of subjects: 60
Study 11996212 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 x 20 mg capsules
Number of subjects: 60
Study 11996212 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x 20 mg capsules
Number of subjects: 60
Study 9476972 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral delta9-tetrahydrocannabinol (delta9-THC) 7.5 mg
Number of subjects: 35
Study 9476972 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral delta9-tetrahydrocannabinol (delta9-THC) 15 mg
Number of subjects: 35
Study 9476972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 7666121 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin 800 mg i.v. every 24 hours
Number of subjects: 90
Study 7666121 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin 800 mg per os every 24 hours
Number of subjects: 90
Study 7666121 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg per os every 12 hours
Number of subjects: 90
Study 2698804 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate (MPSS) 125 mg/day intravenous for 8 weeks
Number of subjects: 403
Study 2698804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study 4910188 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 93
Study 4910188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 31163279 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental arm
Number of subjects: 161
Study 31163279 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 161
Study 28100606 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive Hyperglycemia and Hypoglycemia Minimization (PHHM)
Number of subjects: 30
Study 28100606 — intervention group
Group type: COMPARATOR
Intervention: Predictive Low-Glucose Insulin Suspension (PLGS)
Number of subjects: 30
Study 25739904 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg intraventricular TPA every 12 h (five doses)
Number of subjects: 12
Study 25739904 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 12 h (five doses)
Number of subjects: 12
Study 24517060 — intervention group
Group type: EXPERIMENTAL
Intervention: Yishen Qingli Granule (YQG) combined with low-dose Tripterygium Wilfordii multiglycoside Tablet (TWT)
Number of subjects: 231
Study 24517060 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo for YQG and TWT)
Number of subjects: 231
Study 21946446 — intervention group
Group type: EXPERIMENTAL
Intervention: Teuffel‐Mignon (TF) device
Number of subjects: 118
Study 21946446 — intervention group
Group type: EXPERIMENTAL
Intervention: Coxa‐Flex (CF) device
Number of subjects: 118
Study 19683095 — intervention group
Group type: EXPERIMENTAL
Intervention: WRITE Symptoms (a Written Representational Intervention To Ease Symptoms), a web‐based, symptom management intervention for women with recurrent ovarian cancer.
Number of subjects: 0
Study 16963658 — intervention group
Group type: EXPERIMENTAL
Intervention: FSC 250/50
Number of subjects: 185
Study 16280561 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of depressive symptoms
Number of subjects: 0
Study 16280561 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlling for prior history of depression, increased life stress, and current psychoactive medication
Number of subjects: 0
Study 11573100 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subcitrate 120 mg plus metronidazole 250 mg plus tetracycline 250 mg qid plus omeprazole 20 mg bid for 7 days (OBMT)
Number of subjects: 161
Study 9400034 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (600 mg/day for 7 days, then 200 mg/day until discharge)
Number of subjects: 124
Study 9400034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 9400034 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 124
Study 7960359 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole alone
Number of subjects: 64
Study 7960359 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole + topical 0.1% fluocinolone acetonide
Number of subjects: 64
Study 7960359 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole + topical 0.05% clobetasol propionate
Number of subjects: 64
Study 7960359 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 64
Study 3654034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetropium bromide 50 mg, p.o. 3 times per day for 1 week
Number of subjects: 22
Study 3654034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (exact dosage not specified)
Number of subjects: 22
Study 3654034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 31724349 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Renying (ST 9) applied once a day, 6 times a week for 4 weeks.
Number of subjects: 80
Study 31724349 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (control group treatment).
Number of subjects: 80
Study 29156299 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (CA-125 and transvaginal ultrasound annually for 3-5 years)
Number of subjects: 78215
Study 29156299 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm
Number of subjects: 78215
Study 29156299 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 78215
Study 26416334 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy with booster sessions
Number of subjects: 75
Study 26416334 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus manual therapy
Number of subjects: 75
Study 26416334 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 75
Study 26416334 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus manual therapy with booster sessions
Number of subjects: 75
Study 26416334 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy in consecutive sessions
Number of subjects: 75
Study 23168337 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy
Number of subjects: 684
Study 22101876 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet enriched with carp meat (200 g twice weekly for 4 weeks)
Number of subjects: 143
Study 22101876 — intervention group
Group type: COMPARATOR
Intervention: Standard spa diet
Number of subjects: 143
Study 19747918 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (90 microg/week) maintenance therapy
Number of subjects: 764
Study 19747918 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 764
Study 17011184 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral capecitabine
Number of subjects: 60
Study 17011184 — intervention group
Group type: COMPARATOR
Intervention: Nordic bolus FL
Number of subjects: 60
Study 15122434 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 second response speed
Number of subjects: 69
Study 11105526 — intervention group
Group type: EXPERIMENTAL
Intervention: Rereading texts
Number of subjects: 0
Study 11105526 — intervention group
Group type: COMPARATOR
Intervention: Reading texts once
Number of subjects: 0
Study 9631802 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cysteine (NAC) 150 mg/kg bolus, followed by a continuous infusion of 50 mg/kg over 4 hours (n=12)
Number of subjects: 22
Study 9631802 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cysteine (NAC)
Number of subjects: 22
Study 9631802 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=10)
Number of subjects: 22
Study 7874838 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interleukin-2 (18 x 10(6) i.u./day)
Number of subjects: 18
Study 7874838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2963663 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 micrograms ethinyl oestradiol + Cyproterone acetate
Number of subjects: 0
Study 2963663 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms ethinyl oestradiol + Cyproterone acetate
Number of subjects: 0
Study 2963663 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31789060 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls efficacy (Short Falls Efficacy Scale‐International)
Number of subjects: 115
Study 31789060 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of falling (one‐item question)
Number of subjects: 115
Study 31789060 — intervention group
Group type: EXPERIMENTAL
Intervention: Low perceived ability to manage falls
Number of subjects: 115
Study 31366977 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation-specific PCR (MSP)
Number of subjects: 0
Study 31366977 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrosequencing (PYR)
Number of subjects: 0
Study 31366977 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP and PYR in tissue
Number of subjects: 0
Study 28501537 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (3 times/week for 12 weeks)
Number of subjects: 27
Study 28501537 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 27
Study 28501537 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and Control
Number of subjects: 27
Study 25948208 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Zaofan pill combined with cyclosporine and androgen
Number of subjects: 76
Study 25948208 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine and androgen alone
Number of subjects: 76
Study 25948208 — intervention group
Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 76
Study 23647981 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 38
Study 21257829 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 60
Study 21257829 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 60
Study 18061593 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening for aneuploidy
Number of subjects: 0
Study 18061593 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prescreening)
Number of subjects: 0
Study 17069814 — intervention group
Group type: EXPERIMENTAL
Intervention: C11994T mutation in the ND4 gene
Number of subjects: 34
Study 17069814 — intervention group
Group type: COMPARATOR
Intervention: Normozoospermic fertile men
Number of subjects: 34
Study 12620132 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrally acting antihypertensive drugs and beta‐adrenergic blockers
Number of subjects: 0